300878 維康藥業
按盤價 
19.440 -0.440 (-2.213%)
19.440 -0.440 (-2.213%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.221 | -0.577 | 3.492 | 6.946 | 14.290 |
| 總資產報酬率 ROA (%) | 2.272 | -0.406 | 2.706 | 5.809 | 10.845 |
| 投入資產回報率 ROIC (%) | 2.471 | -0.445 | 3.001 | 6.618 | 9.503 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.389 | 50.394 | 58.854 | 67.711 | 72.475 |
| 營業利潤率 (%) | 12.960 | -0.195 | 12.180 | 15.663 | 25.537 |
| 息稅前利潤/營業總收入 (%) | 12.349 | 0.342 | 12.485 | 15.324 | 24.631 |
| 淨利潤/營業總收入 (%) | 12.459 | -1.190 | 9.293 | 15.253 | 21.791 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -100.089 | 699.013 | 60.840 | 95.034 | 85.834 |
| 價值變動淨收益/利潤總額(%) | 210.157 | -318.577 | 23.418 | 0.264 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -9.659 | 82.483 | -2.694 | 0.886 | -0.212 | 償債能力分析 |
| 流動比率 (X) | 5.165 | 2.400 | 2.503 | 3.744 | 4.674 |
| 速動比率 (X) | 4.450 | 2.043 | 2.220 | 3.187 | 4.289 |
| 資產負債率 (%) | 25.667 | 31.233 | 26.298 | 16.789 | 15.005 |
| 帶息債務/全部投入資本 (%) | 18.412 | 22.128 | 16.927 | 3.468 | -- |
| 股東權益/帶息債務 (%) | 428.399 | 337.814 | 471.542 | 2,683.577 | 44,554.298 |
| 股東權益/負債合計 (%) | 286.278 | 217.420 | 277.632 | 491.521 | 565.176 |
| 利息保障倍數 (X) | 23.255 | 0.235 | 19.990 | -31.993 | -28.897 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 168.237 | 167.576 | 218.148 | 187.383 | 0.000 |
| 存貨周轉天數 (天) | 181.872 | 188.939 | 202.341 | 186.537 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 12:31 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
